Rare Constitutional and hereditary Diseases, Whole Exome Sequence Analysis, NGS
The human exome represents less than 2% of the genome but contains ~85% of known disease-related variants. Whole exome sequencing (WES) utilizes next generation sequencing (NGS) to simultaneously identify and analyze the sequences of all protein-coding genes in an individual’s genome. The diagnostic utility of exome sequencing has consistently been 20%-30% (i.e., a known pathogenic variant is identified in 20%-30% of individuals who were previously undiagnosed but had features suggestive of a genetic condition). However, due to the fact that it evaluates millions of bases, WES typically identifies large numbers of ‘variations’ in an individual’s exome. Each variant must be evaluated by an individual with expertise in genetic conditions to determine if it is a benign variant, a disease causing variant or a novel variant that may or may not be clinically relevant (variant of unknown significance). Unfortunately, in many cases the finding of a genetic variation is either non-diagnostic or fails to provide clinically useful information that impacts therapy.
Sequence analysis of the exome is typically performed by target enrichment or capture of exons followed by next-generation sequencing (NGS). Exome sequencing techniques have non-standardized, highly variable coverage; of particular note are regions of the exome refractory to accurate sequencing by this method (including genes with a pseudogene, highly repetitive coding regions, and large deletions and duplications). Laboratories may also include sequence analysis of some noncoding regions of the genome (e.g., promoters, highly conserved regulatory sequences). Although the term "whole-exome sequencing" is used, coverage of the exome is less than 100%. Thus, the "whole" exome is not sequenced. Therefore, the term ‘exome sequencing’ is preferred over the formerly used term ‘whole-exome sequencing’.
- When other genetic testing options are exhausted
- Patients with a long list of differential diagnosis
- Atypical presentation of disease
- Provides a cost-effective alternative to whole-genome sequencing (4–5 Gb of sequencing per exome compared to ~90 Gb per whole human genome)
- Produces a smaller, more manageable data set for faster, easier data analysis compared to whole-genome sequencing
Abnormal
Variants or mutations detected within the coding regions (exons). When abnormal, usually reported as:
- Likely causative (pathogenic) variants: Detected (e.g. one homozygous variant was identified, giving the name and mutation of the gene)
- Possibly Relevant Variants: Detected (One heterozygous variants of uncertain significance (VUS) was identified, giving the name and mutation of the gene)
- Variants in Genes of Uncertain Significance (GUS): Detected (One homozygous variant was identified, given the name of the gene and mutation)
- Secondary Findings (other reported): One heterozygous pathogenic variant was identified, given the name of the gene and mutation)
Normal
Variants or mutations not detected within the coding regions (exons). Usually reported as:
- Likely causative (pathogenic) variants: not detected (not identified) or detected (e.g. one homozygous variant was identified
- Possibly Relevant Variants: not detected (not identified)
- Variants in Genes of Uncertain Significance (GUS): not detected (not identified)
- Secondary Findings (other reported): No reportable variants identified
No variants or mutations detected within the coding regions (exons)
Whole blood (EDTA), tissues, amniotic fluid, CVS other sources.
Stability (Blood)
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Genet Med. 2021 Nov;23(11):2029-2037. [PMID: 34211152]
- JAMA. 2014 Nov;312(18):1870-1879. [PMID: 25326635]
- BMC Genomics. 2017;18: 517. [PMID: 28683819]
- Genomics. 2016;108: 109-114. [PMID: 27387609]
- Proc Natl Acad Sci U S A. 2015;112: 5473-8. [PMID: 25827230]
- Eur J Hum Genet. 2012;20: 490-7. [PMID: 22258526]
- Ann Neurol. 2012;71:5-14. [PMID: 22275248]
- Am J Hum Genet. 2012;91: 597-607. [PMID: 23040492]
- Nat Rev Genet. 2011;12: 745-55. [PMID: 21946919]